Sammanfattning
The disclosure relates to the development of methods for making hematopoietic stem cells from differentiated cells by introducing and expressing transcription factors. More particularly, the disclosure provides methods for redirecting differentiated cells to a hematopoietic stem cell state or to a hemogenic endothelial cell state by direct programming with specific combinations of transcription factors.
| Originalspråk | engelska |
|---|---|
| Patentnummer | WO2013116307A1 |
| Arkiveringsdatum | 2013/01/30 |
| Status | Published - 2017 |
| Externt publicerad | Ja |
Ämnesklassifikation (UKÄ)
- Cell- och molekylärbiologi